 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--VistaGen Therapeutics, Inc. NASDAQ: VTGN a late clinical-stage, central nervous system CNS-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other CNS disorders, today announced it will host a conference call and webcast on Thursday, June 23, 2022, at 2:00 p.m. Pacific Time 5:00 p.m. Eastern Time to report its financial results for fiscal year 2022 ending on March 